45 WIGGINS AVENUE, BEDFORD, MA
Market cap: $1.8B (2/08/2026)
Price: $31.99
Material disclosure
Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome
Stoke Therapeutics and Biogen Showcase Zorevunersen's Potential at AES 2025
Earnings Release
News, Material Contracts
Amended material disclosure
Reports Second Quarter 2025 Financial Results and Provides Business Updates
Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome
Q3
Q2
Q1
FY 2024
FY 2023
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities